Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2020-07-01
Summary
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
Conditions
Interventions
- OTHER
-
Questionnaires
standardized data collection and 10-year prospective follow-up
Sponsors & Collaborators
-
UNICANCER - Le Groupe génétique et cancer (GGC)
collaborator UNKNOWN -
Institut Paoli-Calmettes
lead OTHER
Principal Investigators
-
Catherine NOGUES, MD · Institut Paoli-Calmettes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-10-15
- Primary Completion
- 2028-10-15
- Completion
- 2028-10-15
Countries
- France
Study Locations
More Related Trials
-
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
NCT00040222 ·Status: COMPLETED
-
BRCA Mutation Carriers' Platform a Multicenter Study
NCT07253051 ·Status: RECRUITING
-
BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival
NCT02317120 ·Status: COMPLETED
-
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
NCT03246841 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
NCT00006421 ·Status: COMPLETED
-
Korean Hereditary Breast Cancer Study
NCT00595348 ·Status: UNKNOWN
-
Outcomes of Education and Counseling for BRCA1 Testing
NCT00001468 ·Status: COMPLETED
-
Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT04842799 ·Status: COMPLETED ·Phase: NA
-
Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations
NCT00579007 ·Status: COMPLETED
-
Management of Women With BRCA1/2 Mutation
NCT03211611 ·Status: COMPLETED
-
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
NCT03673306 ·Status: COMPLETED
-
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
NCT03319290 ·Status: UNKNOWN
-
Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
NCT00757211 ·Status: UNKNOWN
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
NCT04403984 ·Status: UNKNOWN
-
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
NCT01386411 ·Status: COMPLETED
-
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
NCT00896818 ·Status: UNKNOWN
-
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
NCT03396341 ·Status: RECRUITING
-
Assessing Clinical Features and Outcome of Breast Cancer in PALB2 Mutation Carriers: the Palbreast Study
NCT06403904 ·Status: RECRUITING
-
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 ·Status: RECRUITING
-
Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners
NCT06111417 ·Status: RECRUITING
-
Predictive Clinical and Biological Parameters in Breast Cancer
NCT01521676 ·Status: TERMINATED ·Phase: NA
-
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
NCT04668521 ·Status: TERMINATED
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED